Q32 Bio (QTTB) Capital Expenditures (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -81.79% |
| Jun 30, 2025 | -200.00% |
| Mar 31, 2025 | 146.87% |
| Dec 31, 2024 | -299.62% |
| Sep 30, 2024 | 18.39% |
| Jun 30, 2024 | 93.91% |
| Sep 30, 2023 | -200.00% |
| Jun 30, 2023 | 3,720.00% |
| Mar 31, 2023 | -44.44% |
| Dec 31, 2022 | 50.00% |
| Sep 30, 2022 | -99.50% |
| Jun 30, 2022 | 1,952.54% |
| Mar 31, 2022 | -71.50% |
| Dec 31, 2021 | 445.00% |
| Sep 30, 2021 | 91.70% |
| Jun 30, 2021 | -188.49% |
| Mar 31, 2021 | 130.62% |
| Dec 31, 2020 | -1,799.36% |
| Sep 30, 2020 | -92.92% |
| Jun 30, 2020 | 447.16% |
| Mar 31, 2020 | 278.41% |
| Dec 31, 2019 | 98.55% |
| Sep 30, 2019 | -241.33% |
| Jun 30, 2019 | 110.68% |
| Mar 31, 2019 | -66.89% |
| Dec 31, 2018 | 230.16% |
| Sep 30, 2018 | 16.07% |
| Jun 30, 2018 | 15,296.30% |
| Mar 31, 2018 | -91.98% |
| Dec 31, 2017 | -77.16% |
| Sep 30, 2017 | 310.14% |
| Jun 30, 2017 | -182.71% |